Evidence map›Paper›PMID 41911267›Full record

ReviewJournal of proteome research2026

A Framework for Database Search with AI Models in Mass Spectrometry-Based Proteomics.

Konstantinos Kalogeropoulos, Jeroen Van Goey, Timothy P Jenkins, Kevin Michael Eloff

Abstract readReview
In one paragraph

Review in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Konstantinos KalogeropoulosDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby 2800, Denmark.ORCID 0000-0003-3907-9281
Jeroen Van GoeyInstaDeep Ltd, 5 Merchant Square, London W2 1AY, UK.
Timothy P JenkinsDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby 2800, Denmark.ORCID 0000-0003-2979-5663
Kevin Michael EloffInstaDeep Ltd, 5 Merchant Square, London W2 1AY, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Database search remains the primary strategy for peptide detection in mass spectrometry-based proteomics, but growing data sets and increasingly expansive peptide search spaces now challenge its computational limits. At the same time, machine learning has transformed multiple aspects of spectrum identification and is increasingly applied directly to peptide-spectrum matching. Neural network models have been proposed as core engines for database search, yet the computational complexities of such approaches have not been systematically defined or compared. Here, we present a range of emerging approaches for database search and a theoretical framework for runtime and scaling in spectrum identification, contrasting classical search strategies with emerging neural network-based methods. We analyze asymptotic complexity in the number of spectra and peptide candidates and estimate practical wall time and memory requirements under realistic hardware assumptions. Our framework highlights trade-offs and provides a guide for selecting and developing scalable peptide search strategies in the era of large models and proteomics data sets. We therefore consider whether learned scoring models may progressively replace or augment classical similarity functions at the peptide-spectrum scoring level.

Indexed as

Databases, ProteinMass SpectrometryProteomicsAlgorithmsMachine LearningNeural Networks, ComputerPeptidesPeptidesAI modelsdatabase searchde novo peptide sequencinghybrid proteomics searchesmachine learningmass spectrometrypeptide spectrum matchproteomicsreference database

Identifiers

PMID41911267
PMCPMC13142651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.